Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on January 10, 2012. The filing serves as a Regulation FD disclosure regarding upcoming communications with securities analysts and investors scheduled for the same date.
Key Financial Metrics
The filing does not provide historical financial statements, revenue, profit, cash flow, or debt figures for the period. The only specific financial metric disclosed is the reaffirmed earnings per share (EPS) guidance for the full year 2011.
- 2011 Full Year EPS Guidance: $7.18 to $7.28 per share.
- Net Investment Gains Included: $0.28 per share.
- Investment Outlook Assumption: No additional investment gains or losses beyond those recorded in the first three quarters of 2011.
Material Changes
The filing does not report material changes to financial results or operations compared to prior periods. It confirms the continuation of previously issued guidance for the 2011 fiscal year.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management expects to reaffirm the 2011 EPS range during analyst meetings on January 10, 2012. Detailed guidance for the 2012 fiscal year is scheduled to be provided during the fourth-quarter earnings call on January 25, 2012.
Risks and Contingencies
The filing includes a comprehensive Safe Harbor statement identifying numerous risks that could cause actual results to differ from projections, including:
- Impact of the Patient Protection and Affordable Care Act and related regulations.
- Trends in health care costs, utilization rates, and premium rate approvals.
- Competitor pricing and changes in product mix or enrollment.
- Risks related to Medicare and Medicaid programs, including funding and compliance.
- Financial strength rating downgrades and litigation outcomes.
- Compliance with the Express Scripts, Inc. pharmacy benefit management agreement.
- Information system failures and data security breaches.
- License risks with the Blue Cross and Blue Shield Association.
- Impairment of intangible assets and goodwill.
- General economic downturns and investment portfolio volatility.
Investor Verification Checklist
- Verify the actual 2011 full-year earnings per share against the reaffirmed range of $7.18 to $7.28.
- Monitor the January 25, 2012, earnings call for the release of 2012 guidance.
- Review subsequent filings for updates on the Express Scripts agreement compliance and potential penalties.
- Assess the impact of Affordable Care Act regulations on premium rates and enrollment trends as outlined in the risk factors.
- Confirm the company's financial strength ratings and any changes in litigation reserves.